H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 71 Citations 19,391 235 World Ranking 992 National Ranking 4
Medicine D-index 92 Citations 40,602 449 World Ranking 5506 National Ranking 11

Research.com Recognitions

Awards & Achievements

2019 - Fellow of the Royal Society, United Kingdom

2012 - Member of the National Academy of Medicine (NAM)

2009 - Fellow, The World Academy of Sciences

Fellow of the Royal Society of South Africa

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Acquired immunodeficiency syndrome
  • Internal medicine
  • Virus

His primary areas of study are Immunology, Virology, Acquired immunodeficiency syndrome, Antibody and Epitope. His studies link Gp41 with Virology. His biological study spans a wide range of topics, including Psychological intervention, Young adult, Internal medicine, Demography and Public health.

Salim S. Abdool Karim combines subjects such as Microbicides for sexually transmitted diseases, Rectal microbicide, Surgery and Pre-exposure prophylaxis with his study of Internal medicine. Salim S. Abdool Karim has included themes like Cross-sectional study, Condom and Incidence in his Demography study. The Public health study combines topics in areas such as Transmission, Health care and Developing country.

His most cited work include:

  • Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women (2103 citations)
  • Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial (736 citations)
  • Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy (537 citations)

What are the main themes of his work throughout his whole career to date?

Salim S. Abdool Karim mostly deals with Virology, Immunology, Acquired immunodeficiency syndrome, Antibody and Viral load. The study incorporates disciplines such as Epitope, Microbicides for sexually transmitted diseases and Microbicide in addition to Virology. His Immunology research integrates issues from Bacterial vaginosis and Cohort.

His study in Acquired immunodeficiency syndrome is interdisciplinary in nature, drawing from both Incidence, Demography, Family medicine, Transmission and Public health. His work deals with themes such as Internal medicine and Viral replication, which intersect with Viral load. His research investigates the link between Internal medicine and topics such as Tuberculosis that cross with problems in Clinical trial.

He most often published in these fields:

  • Virology (43.67%)
  • Immunology (46.33%)
  • Acquired immunodeficiency syndrome (32.83%)

What were the highlights of his more recent work (between 2017-2021)?

  • Virology (43.67%)
  • Viral load (23.17%)
  • Immunology (46.33%)

In recent papers he was focusing on the following fields of study:

Salim S. Abdool Karim focuses on Virology, Viral load, Immunology, Antibody and Internal medicine. His studies in Virology integrate themes in fields like Epitope, HIV vaccine and Coronavirus disease 2019. His Viral load study incorporates themes from Lipopolysaccharide binding protein, Point-of-care testing, Task shifting and Tuberculosis.

His Immunology study combines topics from a wide range of disciplines, such as Bacterial vaginosis and Reproductive health. His research investigates the connection with Antibody and areas like Trogocytosis which intersect with concerns in Antigenic variation. As a member of one scientific family, Salim S. Abdool Karim mostly works in the field of Pharmacokinetics, focusing on Phases of clinical research and, on occasion, Acquired immunodeficiency syndrome.

Between 2017 and 2021, his most popular works were:

  • Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women. (61 citations)
  • Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women. (61 citations)
  • SARS-CoV-2 variants and ending the COVID-19 pandemic. (57 citations)

In his most recent research, the most cited papers focused on:

  • Acquired immunodeficiency syndrome
  • Internal medicine
  • Virus

The scientist’s investigation covers issues in Viral load, Virology, Internal medicine, Immunology and Tuberculosis. His Viral load research is multidisciplinary, incorporating perspectives in Clinical trial, MEDLINE, Treatment outcome, Regimen and Intensive care medicine. His Regimen research includes elements of Demography, Sequence analysis, Drug resistance and Acquired immunodeficiency syndrome.

The Virus research he does as part of his general Virology study is frequently linked to other disciplines of science, such as Limiting, therefore creating a link between diverse domains of science. His studies deal with areas such as Test, Point of care, Task shifting and Point-of-care testing as well as Internal medicine. Salim S. Abdool Karim has researched Tuberculosis in several fields, including HIV drug resistance, Tolerability, Cohort study and Dolutegravir.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

Quarraisha Abdool Karim;Salim S. Abdool Karim;Janet A. Frohlich;Anneke C. Grobler.
Science (2010)

2976 Citations

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

Lut Van Damme;Gita Ramjee;Michel Alary;Bea Vuylsteke.
The Lancet (2002)

973 Citations

Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

Salim S. Abdool Karim;Kogieleum Naidoo;Anneke Grobler;Nesri Padayatchi.
The New England Journal of Medicine (2010)

850 Citations

Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

Georgia D. Tomaras;Nicole L. Yates;Pinghuang Liu;Li Qin.
Journal of Virology (2008)

710 Citations

Health in South Africa: changes and challenges since 2009

Bongani M. Mayosi;Joy E. Lawn;Ashley. Van Niekerk;Ashley. Van Niekerk;Debbie. Bradshaw.
The Lancet (2012)

642 Citations

HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.

Salim Safurdeen. Abdool Karim;Salim Safurdeen. Abdool Karim;Gavin J. Churchyard;Quarraisha. Abdool Karim;Quarraisha. Abdool Karim;Stephen D. Lawn.
The Lancet (2009)

639 Citations

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore.
Nature (2014)

616 Citations

Integration of antiretroviral therapy with tuberculosis treatment

Salim Safurdeen. Abdool Karim;Kogieleum. Naidoo;Anna Christina. Grobler;Nesri. Padayatchi.
The New England Journal of Medicine (2011)

590 Citations

The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners.

Mark N. Lurie;Brian G. Williams;Khangelani Zuma;David Mkaya-Mwamburi.
Sexually Transmitted Diseases (2003)

576 Citations

The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection

Elin S. Gray;Maphuti C. Madiga;Tandile. Hermanus;Penny L. Moore.
Journal of Virology (2011)

489 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Salim S. Abdool Karim

David C. Montefiori

David C. Montefiori

Duke University

Publications: 276

Barton F. Haynes

Barton F. Haynes

Duke University

Publications: 248

Georgia D. Tomaras

Georgia D. Tomaras

Duke University

Publications: 199

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 177

John R. Mascola

John R. Mascola

National Institutes of Health

Publications: 158

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 138

Dennis R. Burton

Dennis R. Burton

Scripps Research Institute

Publications: 132

Lynn Morris

Lynn Morris

University of the Witwatersrand

Publications: 130

Bette T. Korber

Bette T. Korber

Los Alamos National Laboratory

Publications: 121

Michael S. Seaman

Michael S. Seaman

Beth Israel Deaconess Medical Center

Publications: 115

Hua-Xin Liao

Hua-Xin Liao

Jinan University

Publications: 110

Linda-Gail Bekker

Linda-Gail Bekker

University of Cape Town

Publications: 107

Philip J. R. Goulder

Philip J. R. Goulder

University of Oxford

Publications: 102

Rogier W. Sanders

Rogier W. Sanders

University of Amsterdam

Publications: 102

Peter D. Kwong

Peter D. Kwong

National Institutes of Health

Publications: 100

Penny L. Moore

Penny L. Moore

National Health Laboratory Service

Publications: 99

Something went wrong. Please try again later.